Agilon Health (AGL) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Agilon Health (AGL) do?
Agilon Health Inc (AGL) is a U.S.-listed company in Healthcare (Medical Care Facilities). What it does: Provides primary care physicians with technology, support staff, and capital to manage Medicare Advantage plans. It partners with local primary care doctors to transition senior patient care into risk-sharing Medicare networks. It is worth $1.50B on the market and sold $6.01B over the last year.
- Market cap
- $1.50B
- P/E ratio
- None (reported a loss)
- Annual sales
- $6.01B
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Brief updated
- Nov 17, 2026
AGL’s flags, in plain English
Each flag is a number from Agilon Health’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.
Still Climbing
Sales up 37.2% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Insiders Hold
Insiders own 30.2% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Low debt
Low debt, only 12% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Burning Cash
Losing money, profit margin of -1.8%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
2 more risk notes open with the free trial. Try it free for 7 days.
Questions about AGL
How big is Agilon Health?
Agilon Health’s market cap is $1.50B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $6.01B: what customers paid the company over the last year, before any costs.
What is AGL’s P/E ratio?
AGL has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with AGL?
The company faces elevated medical claims costs among Medicare Advantage patients that outpace contracted health plan payments. That is one risk on Agilon Health’s card. Its first risk flag is Burning Cash, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Agilon Health’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. AGL’s filings on SEC.gov. The Margin Monkey is research, not advice.
